AI-generated summary
This study protocol describes a planned randomized controlled trial comparing conventional venous ulcer treatment with conventional care plus adjuvant low-level laser therapy, with healing assessed using Nursing Outcomes Classification indicators. The authors report that the trial will enroll 40 adults with active venous ulcers. No results are reported, so the trial's effect on healing is not yet known.
- Participants
- 40
- Who or what was studied
- Adults of both sexes with active venous ulcers (planned enrollment of 40)
- Limits stated in the abstract
- This is a protocol only, with no outcome data reported, and the planned sample size of 40 is small.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Background
Different methods are available for the treatment of venous ulcers. Most current approaches focus on a combination of topical and compressive therapy. Adjuvant low-level laser therapy may be helpful in lesions with a protracted healing course, but evidence for its use is still limited. This paper describes the protocol of a randomized controlled trial designed to compare the effect of adjuvant low-level laser therapy versus conventional venous ulcer tissue repair, evaluated by a nurse using clinical indicators from the Nursing Outcomes Classification (NOC).
Methods/Design
For this prospective randomized controlled trial, 40 adult patients of both sexes with active venous ulcers will be recruited. Subjects will be selected by the sealed-envelope method without any annotation or external identification that might refer to the type of study group. At the time of unblinding, a label with the description of the group to which the patient belongs (that is, control or intervention) will be found inside the envelope. Conventional treatment (topical medication and compressive therapy) will be offered to both groups. Additionally, the intervention group will receive adjuvant low-level laser therapy. All patients will be followed weekly until ulcer healing or for a maximum of 16 weeks. Evaluation of tissue repair will be based on 14 clinical indicators drawn from NOC for wound healing (secondary intention) and tissue integrity (skin and mucous membranes). The primary endpoint will be decreased wound size and scar formation. This laser therapy is expected to enhance the quality, speed, and effectiveness of the treatment of venous ulcers, a chronic condition. This should reduce associated costs to the health service and allow patients to resume their daily activities sooner.
Discussion
This randomized clinical trial will use a validated method to investigate the effect of a novel intervention for the treatment of venous ulcers.
Trial Registration
ClinicalTrials.gov, NCT03229330 . Registered on July 2017.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Low-level laser therapy, Randomized controlled trial, Trial registration, Wound healing. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.